Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Troels Mygind Jensen"'
Autor:
Steffan Holst Hansen, Troels Mygind Jensen, Gitte Stentebjerg Petersen, Francois Pouwer, Anders Larrabee Sonderlund, Jens Søndergaard
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Background Diabetes distress (DD) affects at least 36% of T2DM patients and is often associated with insufficient support and care. This study examines an intervention that targets DD through enhanced cross-sectoral collaboration and treatme
Externí odkaz:
https://doaj.org/article/0bfa1625bd94419e83279a01e38426aa
Autor:
Troels Mygind Jensen, Nicklas Freisleben Lund, Stine Grønbæk Jensen, Anne Hagen Berg, Anne Marie Mai, Klaus Petersen, Kaare Christensen, Jacob Krabbe Pedersen, Jens Søndergaard, Peter Simonsen
Publikováno v:
Journal of Ageing and Longevity, Vol 3, Iss 2, Pp 153-158 (2023)
Recent decades have witnessed the coming of age of ‘literary gerontology’, a discipline situated at the intersection of literary studies and gerontology. A key argument of this research is that literature and literary criticism can highlight the
Externí odkaz:
https://doaj.org/article/5e6a860294814a29966d90638dffabe4
Autor:
Steffan Holst Hansen, Troels Mygind Jensen, Gitte Stentebjerg Petersen, Francois Pouwer, Anders Larrabee Sonderlund, Jens Søndergaard
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/cec2929b97bc4df7a6bcec3ea90e0c0b
Autor:
Magdalena Keindl, Olena Fedotkina, Elsa du Plessis, Ruchi Jain, Brith Bergum, Troels Mygind Jensen, Cathrine Laustrup Møller, Henrik Falhammar, Thomas Nyström, Sergiu-Bogdan Catrina, Gun Jörneskog, Leif Groop, Mats Eliasson, Björn Eliasson, Kerstin Brismar, Peter M. Nilsson, Tore Julsrud Berg, Silke Appel, Valeriya Lyssenko
Publikováno v:
Frontiers in Endocrinology, Vol 11 (2020)
Type 1 diabetes (T1D) is largely considered an autoimmune disease leading to the destruction of insulin-producing pancreatic β cells. Further, patients with T1D have 3–4-fold increased risk of developing micro- and macrovascular complications. How
Externí odkaz:
https://doaj.org/article/d836a8f3cf7f4ae882011f98d643933f
Autor:
Kasper Olesen, Troels Mygind Jensen, Lars Jorge Diaz, Anne Cathrine Laustrup Møller, Ingrid Willaing, Valeriya Lyssenko
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 8, Iss C, Pp 1-5 (2017)
Aim: It is a constant challenge for people with type 1 diabetes to maintain appropriate levels of HbA1c, blood pressure and blood lipids in order to prevent or delay deleterious effects of their illness. This study sought to investigate if Sense of C
Externí odkaz:
https://doaj.org/article/c511a644e25e47398d0cd31a7008c90d
Autor:
Troels Mygind Jensen, Frans Boch Waldorff, Kaare Christensen, Jacob Pedersen, Jens Søndergaard
Publikováno v:
Pedersen, J K, Jensen, T M, Waldorff, F B, Søndergaard, J & Christensen, K 2020, ' Use of prescription medication in the last years of life : a population-based comparison of two oldest old Danish birth cohorts born 10 years apart ', Age and Ageing, vol. 49, no. 6, pp. 1105-1109 . https://doi.org/10.1093/ageing/afaa064
Introduction Age limits for diagnostics and treatments have been largely removed and replaced by an active diagnostic and treatment practice among the oldest old and has led to concerns about potential overtreatment during the last years of life. Met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9af79f07262dac3ed38651a3112ba83b
https://portal.findresearcher.sdu.dk/da/publications/a5194e16-df4c-463a-a8b8-c620c6cb6abd
https://portal.findresearcher.sdu.dk/da/publications/a5194e16-df4c-463a-a8b8-c620c6cb6abd
Autor:
Troels Mygind Jensen, Peter M. Nilsson, Türküler Özgümüs, Marja-Riitta Taskinen, Carol Forsblom, Thomas Nyström, Kerstin Brismar, Gun Jörneskog, Jani K. Haukka, Tore Julsrud Berg, Mats Eliasson, Peter Rossing, Henrik Falhammar, Ruchi Jain, Leon Eyrich Jessen, Sergiu-Bogdan Catrina, Peter Spégel, Björn Eliasson, Cathrine Laustrup Møller, Mahmoud Al-Majdoub, Valeriya Lyssenko, Ele Ferrannini, Elsa du Plessis, Per-Henrik Groop, Leif Groop, Magdalena Keindl
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-12 (2020)
Jain, R, Özgümüş, T, Jensen, T M, du Plessis, E, Keindl, M, Møller, C L, Falhammar, H, Nyström, T, Catrina, S B, Jörneskog, G, Jessen, L E, Forsblom, C, Haukka, J K, Groop, P H, Rossing, P, Groop, L, Eliasson, M, Eliasson, B, Brismar, K, Al-Majdoub, M, Nilsson, P M, Taskinen, M R, Ferrannini, E, Spégel, P, Berg, T J & Lyssenko, V 2020, ' Liver nucleotide biosynthesis is linked to protection from vascular complications in individuals with long-term type 1 diabetes ', Scientific Reports, vol. 10, no. 1, 11561 . https://doi.org/10.1038/s41598-020-68130-y
Scientific Reports
Jain, R, Özgümüş, T, Jensen, T M, du Plessis, E, Keindl, M, Møller, C L, Falhammar, H, Nyström, T, Catrina, S B, Jörneskog, G, Jessen, L E, Forsblom, C, Haukka, J K, Groop, P H, Rossing, P, Groop, L, Eliasson, M, Eliasson, B, Brismar, K, Al-Majdoub, M, Nilsson, P M, Taskinen, M R, Ferrannini, E, Spégel, P, Berg, T J & Lyssenko, V 2020, ' Liver nucleotide biosynthesis is linked to protection from vascular complications in individuals with long-term type 1 diabetes ', Scientific Reports, vol. 10, no. 1, 11561 . https://doi.org/10.1038/s41598-020-68130-y
Scientific Reports
Identification of biomarkers associated with protection from developing diabetic complications is a prerequisite for an effective prevention and treatment. The aim of the present study was to identify clinical and plasma metabolite markers associated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0593c96833d9f467c0b7a8346aafede
http://hdl.handle.net/10852/79862
http://hdl.handle.net/10852/79862
Autor:
Lars Jorge Diaz, Anne Cathrine Laustrup Møller, Troels Mygind Jensen, Ingrid Willaing, Kasper Olesen, Valeriya Lyssenko
Publikováno v:
Journal of Clinical & Translational Endocrinology
Journal of Clinical & Translational Endocrinology, Vol 8, Iss C, Pp 1-5 (2017)
Journal of Clinical & Translational Endocrinology, Vol 8, Iss C, Pp 1-5 (2017)
Highlights • SOC was compared to clinical biomarkers in 125 people with type 1 diabetes. • No association between SOC and HbA1c was found. • An independent association between high SOC and lower LDL-C was found.
Aim It is a constant challe
Aim It is a constant challe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b00d46b2a8d2d0469bcdc94d13139276
http://europepmc.org/articles/PMC5651341
http://europepmc.org/articles/PMC5651341
Autor:
Marit E. Jørgensen, Torsten Lauritzen, Peter Rossing, Troels Mygind Jensen, Peter P. Nawroth, Dorte Vistisen, A. Sandbaek, Daniel R. Witte, Thomas Fleming
Publikováno v:
Jensen, T M, Vistisen, D, Fleming, T, Nawroth, P P, Rossing, P, Jørgensen, M E, Lauritzen, T, Sandbæk, A & Witte, D R 2016, ' Methylglyoxal is associated with changes in kidney function among individuals with screen-detected Type 2 diabetes mellitus ', Diabetic Medicine, vol. 33, no. 12, pp. 1625-1631 . https://doi.org/10.1111/dme.13201
Europe PubMed Central
Jensen, T M, Vistisen, D, Fleming, T D, Nawroth, P P, Rossing, P, Jørgensen, M E, Lauritzen, T, Sandbaek, A & Witte, D R 2016, ' Methylglyoxal is associated with changes in kidney function among individuals with screen-detected Type 2 diabetes mellitus ', Diabetic Medicine, vol. 33, no. 12, pp. 1625-1631 . https://doi.org/10.1111/dme.13201
Europe PubMed Central
Jensen, T M, Vistisen, D, Fleming, T D, Nawroth, P P, Rossing, P, Jørgensen, M E, Lauritzen, T, Sandbaek, A & Witte, D R 2016, ' Methylglyoxal is associated with changes in kidney function among individuals with screen-detected Type 2 diabetes mellitus ', Diabetic Medicine, vol. 33, no. 12, pp. 1625-1631 . https://doi.org/10.1111/dme.13201
Aims: The glycolysis-derived metabolite methylglyoxal has been linked to clinical microvascular complications, including diabetic nephropathy. We aimed to further investigate the hypothesis that methylglyoxal is involved in decline in renal function
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31e52312569e270c2d3bd35e389f8c9d
https://doi.org/10.1111/dme.13201
https://doi.org/10.1111/dme.13201
Autor:
Nanna B. Finnerup, Peter P. Nawroth, Troels S. Jensen, Daniel R. Witte, Thomas Fleming, Eva L. Feldman, Morten Charles, Signe T Andersen, Henning Andersen, Brian C. Callaghan, Else-Marie Dalsgaard, Troels Mygind Jensen, Torsten Lauritzen
Publikováno v:
Andersen, S T, Witte, D R, Dalsgaard, E M, Andersen, H, Nawroth, P, Fleming, T, Jensen, T M, Finnerup, N B, Jensen, T S, Lauritzen, T, Feldman, E L, Callaghan, B C & Charles, M 2018, ' Risk factors for incident diabetic polyneuropathy in a cohort with screen-detected type 2 diabetes followed for 13 years : Addition-Denmark ', Diabetes Care, vol. 41, no. 5, pp. 1068-1075 . https://doi.org/10.2337/dc17-2062
Diabetes Care 41, 1068-1075 (2018)
Diabetes Care 41, 1068-1075 (2018)
Tidligere studier af type 2-diabetes viser, at op mod hver anden eller tredje person med diabetes udvikler polyneuropati i løbet af de første 10 år. Polyneuropati kan ikke behandles og forbindes med både højere sygelighed og dødelighed. Dette s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::651cfe45a6c84357dc80d382c03f781a
https://pure.au.dk/portal/da/publications/risk-factors-for-incident-diabetic-polyneuropathy-in-a-cohort-with-screendetected-type-2-diabetes-followed-for-13-years(d2b4e140-93e6-4c73-be5b-d1f2b7154c6e).html
https://pure.au.dk/portal/da/publications/risk-factors-for-incident-diabetic-polyneuropathy-in-a-cohort-with-screendetected-type-2-diabetes-followed-for-13-years(d2b4e140-93e6-4c73-be5b-d1f2b7154c6e).html